Bambusa Therapeutics adopts amended bylaws following IPO

BBTX•2026-11-03

Bambusa Therapeutics adopted amended and restated bylaws and filed an amended and restated certificate of incorporation in Delaware on Nov. 2, 2026, in connection with completing its IPO.

1. IPO-related filings

Bambusa Therapeutics adopted amended and restated bylaws effective Nov. 2, 2026, in connection with completing its initial public offering. It also filed an amended and restated certificate of incorporation in Delaware that day.

Sources

Bambusa Therapeutics adopts amended bylaws following IPO

Sec

Bambusa Therapeutics adopts amended bylaws following IPO

1. IPO-related filings

Related News

Invivyd grants options for 175,000 shares to seven new employees

Meridian Corp: D.A. Davidson cuts rating to neutral from buy and target to $20 from $22

Hemab Therapeutics to report third-quarter financial results

Sources

Bambusa Therapeutics adopts amended bylaws following IPO

Brazil economists raise inflation, rate forecasts after Lula reelection

Upstart Q3 net income up on record contribution profit